The Road Ahead after RESI Boston

29 Sep

By Karen Deyo, Director of Investor Research, Israel BD, LSN

It’s hard to believe that, after more than two years, RESI Boston is now in the rearview for Life Science Nation (LSN). After a great deal of hard work, including a two-day NIA sponsored bootcamp and our first hybrid conference with 900 registered attendees, new and returning sponsors, 14 investor panels, educational workshops and over 50 pitching companies, we can say that face-to-face events are back with a vengeance.

2022_0921_RESIBoston_017

2022_0921_RESIBoston_028

Last week’s RESI was a perfect example of the global ecosystem that LSN fosters. With attendees representing over 30 countries from 6 continents, companies and investors were able to take advantage of RESI’s unique partnering platform to expand their outreach beyond their region. With 2000 meetings taking place, both virtually and in person, RESI was a hive of activity and energy. Whether scheduled ahead of time or ad hoc, the feedback we received from attendees showed that a lot of valuable connections were made.

2022_0921_RESIBoston_005

RESI Boston may be in the rearview but partnering and early-stage deal-making are always ahead of the curve. Keep an eye out for our upcoming conferences, with a virtual-only event in November, and hybrid in San Francisco in January during JP Morgan Healthcare Week, we hope to keep moving the needle forward for the life sciences, one handshake at a time.

2022_0922_RESIBoston_002

RESI-November-2022-2-border

Leave a comment